Company Info
Phone(617) 603-0070
Year Established
2018
Ticker
VERV
Exchange
NASDAQ
Contacts
Morgan JonesSenior Director, Business Development
Company Description
Verve is pioneering single-course gene editing medicines to treat cardiovascular disease
